ClinicalTrials.Veeva

Menu

A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)

Lantheus Medical Imaging logo

Lantheus Medical Imaging

Status

Withdrawn

Conditions

Coronary Artery Disease (CAD)

Treatments

Drug: BMS747158

Study type

Observational

Funder types

Industry

Identifiers

NCT01085162
BMS747158-501

Details and patient eligibility

About

This long-term study will follow patients with known or suspected of having coronary artery disease (CAD) and have participated in present and future BMS747158 clinical studies. The purpose of this study is to evaluate the long-term predictive value associated with BMS747158 Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI).

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have known or suspected CAD
  • Have participated in a BMS747158 clinical study
  • Have received at least 1 dose of BMS747158
  • Provide signed informed consent for this study prior to any follow-up contact
  • Be capable of communicating effectively with study personnel

Exclusion criteria

  • If determined by the Investigator that participation in the study is not in the best interest of the patient or for any sound medical, psychiatric, and/or social reason.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems